Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.94 |
| ▸ | HMGCR | P04035 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | ACLY | P53396 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.42 |
| ▸ | CPT2 | P23786 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL30359537 | 0.97 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL2396390 | 0.97 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL725546 | 0.97 | ALDH1A1 (1.00) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL1331942 | 0.97 | ALDH1A1 (1.00) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL3417188 | 0.97 | ALDH1A1 (1.00) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL240402 | 0.97 | ALDH1A1 (1.00) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL1332229 | 0.97 | ALDH1A1 (1.00) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL842 | 0.97 | ALDH1A1 (1.00) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL10896997 | 0.97 | ALDH1A1 (1.00) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL28641702 | 0.97 | ALDH1A1 (1.00) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109394696-B | Method for preparing liposome | 南京邮电大学 | 2020-12-01 | — | — | CN | claimed |
| WO-2019141264-A1 | DENDRITIC POLYMER NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | claimed |
| WO-2019141266-A1 | HYDROGEL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | claimed |
| WO-2019141271-A1 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | claimed |
| WO-2019141267-A1 | RECOMBINANT BIONIC NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | claimed |
| WO-2019141274-A1 | METAL FRAME COMPOUND NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | claimed |
| WO-2019141278-A1 | NANOSIZED CALCIUM CARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | claimed |
| WO-2019141276-A1 | MESOPOROUS HOLLOW SIO2 NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | claimed |
| WO-2019141265-A1 | MICELLE NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | claimed |
| CN-109394696-A | A kind of preparation method and applications of liposome | 南京邮电大学 | 2019-03-01 | — | — | CN | claimed |
| CN-107937892-A | The phosphatization antirust method of high-efficiency environment friendly neodymium iron boron magnetic body | 廊坊京磁精密材料有限公司 | 2018-04-20 | — | — | CN | claimed |
| CN-103579612-B | A kind of preparation method mixing gadolinium spinel lithium-rich lithium manganate cathode material | FUJIAN NORMAL UNIVERSITY (CN) | 2016-04-20 | — | — | CN | claimed |
| CN-103579612-A | Preparation method for gadolinium-doped spinel lithium-rich lithium manganate cathode material | UNIV FUJIAN | 2014-02-12 | — | — | CN | claimed |
| US-4957939-A | AMINOCARBOXYLIC ACIDS, MEDICAL IMAGING | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-09-18 | — | — | US | claimed |
| CN-119695115-A | Silicon carbon material, preparation method thereof, pole piece, application and lithium ion battery | 上海杉杉新材料有限公司 | 2025-03-25 | — | — | CN | disclosed |
| CN-109394696-B | Method for preparing liposome | 南京邮电大学 | 2020-12-01 | — | — | CN | disclosed |
| WO-2019141267-A1 | RECOMBINANT BIONIC NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE, PREPARATION METHOD THEREFOR, AND USES THEREOF | 北京茵诺医药科技有限公司 | 2019-07-25 | — | — | WO | disclosed |
| WO-1994020997-A1 | SOLID ELECTROLYTE-ELECTRODE SYSTEM FOR AN ELECTROCHEMICAL CELL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1994-09-15 | — | — | WO | disclosed |
| WO-1994005203-A1 | BIOCOMPATIBLE POLYMERS CONTAINING DIAGNOSTIC OR THERAPEUTIC MOIETIES | THE GENERAL HOSPITAL CORPORATION (US) | 1994-03-17 | — | — | WO | disclosed |
| WO-1994003155-A1 | HYDROGEL COMPOSITIONS AND METHODS OF USE | THE GENERAL HOSPITAL CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |